Literature DB >> 23514559

Adrenal metastases.

H Wagnerova1, I Lazurova, M Felsoci.   

Abstract

The adrenal gland is a frequent location for metastatic spread of a various number of malignant tumors. Among all tumors, carcinoma of lung, breast, ovary and malignant melanoma count to the most frequent ones. In nononcological and unselected populations, the prevalence of adrenal metastases is 0-21 %. The metastases are mostly discovered in patients during their follow-up carried out in consequence of their antecedent malignant disease. A malignant disease in adrenal gland may occasionally manifest as a solitary metastasis referred to as adrenal incidentaloma. If the malignant disease is disseminated at the time of adrenal mass diagnosis, no further differentiation of lesion is necessary as it does not influence the further therapeutic process. If the dissemination is not present, further differentiation of adrenal lesion is essential. CT and MRI characteristics of the adrenal mass play the key role in the differential diagnosis. The examination of adrenal overproduction is not necessary in case of known adrenal metastasis except when performing tests in order to rule out the catecholamine overproduction. In case of bilateral metastases, adrenal insufficiency should be also excluded. Surgical treatment is indicated in cases of solitary metastasis. The further management of patients with adrenal metastases belongs to the oncologist. The prognosis of the disease is usually very poor with average survival rate of three months (Fig. 2, Ref. 34).

Entities:  

Mesh:

Year:  2013        PMID: 23514559     DOI: 10.4149/bll_2013_049

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  6 in total

1.  Primary adrenal tuberculosis infection in patients with Behcet's disease presenting as isolated adrenal metastasis by 18F-FDG PET/CT: a rare case report and literature review.

Authors:  Qiliang Teng; Bo Fan; Yutong Wang; Shuang Wen; Honglong Wang; Tianqing Liu; Liang Wang
Journal:  Gland Surg       Date:  2021-12

2.  The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.

Authors:  Raffaele Pezzani; Beatrice Rubin; Loris Bertazza; Marco Redaelli; Susi Barollo; Halenya Monticelli; Enke Baldini; Caterina Mian; Carla Mucignat; Carla Scaroni; Franco Mantero; Salvatore Ulisse; Maurizio Iacobone; Marco Boscaro
Journal:  Invest New Drugs       Date:  2016-05-14       Impact factor: 3.850

3.  Outcome and prognosis after adrenal metastasectomy: nationwide study.

Authors:  Elizabeth Vlk; Andreas Ebbehoj; Frede Donskov; Per Løgstrup Poulsen; Badal Sheiko Rashu; Lasse Bro; Mikael Aagaard; Lars Rolighed
Journal:  BJS Open       Date:  2022-03-08

Review 4.  Cystic adrenal lesions: focus on pediatric population (a review).

Authors:  Mara Carsote; Adina Ghemigian; Dana Terzea; Ancuta Augustina Gheorghisan-Galateanu; Ana Valea
Journal:  Clujul Med       Date:  2017-01-15

5.  Clinical efficacy of chemoembolization with simultaneous radiofrequency ablation for treatment of adrenal metastases from hepatocellular carcinoma.

Authors:  Hongjun Yuan; Fengyong Liu; Xin Li; Yang Guan; Maoqiang Wang
Journal:  Cancer Imaging       Date:  2018-07-31       Impact factor: 3.909

6.  An adrenal incidentaloma caused by synchronous and isolated metastasis.

Authors:  Koichiro Yamamoto; Kosuke Oka; Hiroyuki Honda; Kou Hasegawa; Yoshihisa Hanayama; Tomofumi Watanabe; Yusuke Tominaga; Atsushi Takamoto; Takayuki Hara; Fumio Otsuka
Journal:  Clin Case Rep       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.